Solvent Dependence of (η5-C5Me5)Ir(CO)2 Reactions
Inorganic Chemistry, Vol. 36, No. 6, 1997 1245
Scheme 2. Possible Fluxional Process for Compound 9 in
Solution
supra) indicates that little distortion of this framework would
be expected during the exchange process. In other words, by
only flipping the bridging aryl group without severe distortion
of the framework of the molecule, this exchange would be
energetically facile. This may provide an explanation for the
experimental observation that in the low-temperature NMR for
compound 9 no decoalescence was observed, even at -90 °C.
Notably, similar fluxionality for other σ-π-bridging ligands
has also been observed, for example (µ-σ-CH3CdCH2)(µ-EtS)-
Fe2(CO)6,34a (µ-η1,η3-CHdCdC(CH3)2(µ-t-BuS)Fe2(CO)6,34b
(µ-H)(µ-σ-π-CHdCH2)Re2(CO)7(PPh3),34c (µ-η1,η3-RCdCRC-
(O))M2(CO)(µ-CO)Cp2 (M ) Fe, Ru),34d {µ-EtCdCEt-
(CO2)}Fe2(CO)6,34e (L-L′)Fe2(CO)6 (L-L′ ) µ-C6H5CdCC6H5S
or µ-C6H4CH2NR),34f and (µ-H)(µ-σ-π-CHdCH2)Os3(CO)10.34g
Although the proposed mechanism above can give us a
satisfactory explanation for all of the experimental observations
for 9 in solution, we still lack evidence to rule out completely
the possibility of structure B being the only isomer present in
solution. This type of symmetrically bridged aryl ligand has
ample precedent in the literature.35
Furthermore, the difference of the bond orders between C(3)-
C(4) and C(4)-C(5) would be expected to have some effect
on the -OMe group at C(4). Notably, the bond angle C(3)-
C(4)-O(3) (125.4(7)°) is unusually much more obtuse than
C(5)-C(4)-O(3) (115.2(7)°).
Formation of [Cp*Ir(CO)]2 (4). Our interest in 4 was that
a stoichiometric reaction of it with 1, or 2, equiv of [p-N2C6H4-
OMe][BF4] might result in the known bridging aryldiazenido
complex [Cp*2Ir2(CO)2(η2-µ-p-N2C6H4OMe)][BF4], or the pos-
sible target complex [Cp*Ir(CO)(p-N2C6H4OMe)][BF4] (1).
Considering the exhausting long reaction time (1 week) at 180
°C, and very narrow optimal reaction conditions required by
the available literature method,10 an alternative route to com-
pound 4 was sought, and our efforts were rewarded by several
convenient methods for preparation of this compound. Complex
4 can be smoothly synthesized in excellent yield from readily
available precursors through procedures that consist essentially
of reduction and assembly steps, as shown in Scheme 3.
Considering that the synthetic procedure described in Scheme
3b involves two different precursor compounds, logically, it
could be used in the synthesis of unsymmetrical dinuclear
complexes by changing either the ligand or the metal center of
one precursor. Preliminary trials by using this strategy have
resulted in quantitative syntheses of the unsymmetrical com-
pounds Cp*2IrRh(µ-CO)2 from [Cp*RhCl2]2 and Cp*Ir(CO)2,
and Cp*CpIr2(µ-CO)2 from [Cp*IrCl2]2 and CpIr(CO)2.36
The success of the reduction-assembly method in syntheses
of the above symmetric and unsymmetrical dinuclear complexes
suggests it may have potentially wider utility. It is noticeable
that the literature preparative methods for these types of
Another interesting structural feature of 9 is that despite the
asymmetrically coordinated bridging aryl group, the molecular
framework of Cp*Ir(CO)-Cp*Ir(CO) approximates C2 sym-
metry. This is illustrated by the barely significant difference
in the molecular dimensions of the two Cp*Ir(CO) fragments,
e.g., Ir-CO distances: 1.857(9) Vs 1.858(9) Å; and angles of
Cp*(centroid)-Ir-CO, 127.2 Vs 127.5°, C(O)-Ir-Ir, 91.2(3)
Vs 89.4(3)°, and Cp*(centroid)-Ir-Ir, 130.6 Vs 134.4°. In other
words, the asymmetrical coordination of the aryl ring through
a simultaneous σ and π bonding to the two different iridium
atoms clearly does not cause any significant difference in the
configurations of the two Cp*Ir(CO) fragments.
It should be also pointed out here that although the 1-η1-1,2-
η2- bridging pattern has often been seen in complexes with a
bridging alkenyl or alkynyl ligand that contains an unconjugated
π bond,32 it is rare in a bridged aryl complex. Previously, only
two examples of 1-η1-1,2-η2-bridging aryl complexes have been
reported.33
Possible Molecular Structure of 9 in Solution. Evidently,
the unsymmetrical molecular structure of 9 in the solid state
revealed by its X-ray crystallographic analysis is discrepant with
the spectroscopic data obtained in solution. In order to confirm
that the crystals used for the X-ray crystallographic analysis
have the same chemical composition as that of the bulk samples
1
of 9, further IR and H NMR measurements were made on a
freshly prepared solution from the same group of crystals used
for X-ray structural analysis, and these were identical to the
previous ones. This, together with the absence of any short
intermolecular distance in the crystal lattice, strongly suggests
that a symmetrically bridged aryl ligand required by the
spectroscopic data of 9 in solution is most probably the time-
averaged result of a fast exchange process involved in the
molecule 9. Consequently, an exchange mechanism of the
bridging aryl ligand in 9 is proposed and shown in Scheme 2.
In this mechanism, the bridging aryl ring is rapidly flipping
its relative orientation from structure A, through B, to C and
Vice Versa. Furthermore, the closely related structure and
symmetry of Cp*Ir(CO)-Cp*Ir(CO) in A (or C) and B (Vide
(34) (a) Seyferth, D.; Archer, C. M.; Ruschke, D. P. Organometallics 1991,
10, 3363. (b) Seyferth, D.; Womack, G. B.; Archer, C. M.; Dewan, J.
C. Organometallics 1989, 8, 430. (c) Nubel, P. O.; Brown, T. L. J.
Am. Chem. Soc. 1984, 106, 3475. (d) Dyke, A. F.; Knox, S. A. R.;
Naish, P. J.; Taylor, G. E. J. Chem. Soc., Chem. Commun. 1980, 409.
(e) Aime, S.; Milone, L.; Sappa, E.; Tiripicchio, A.; Tiripicchio-
Camellini, M. J. Chem. Soc., Dalton Trans. 1979, 1155. (f) Hickey,
J. P.; Huffman, J. C.; Todd, L. Inorg. Chim. Acta 1978, 28, 77. (g)
Shapley, J. R.; Richter, S. I.; Tachikawa, M.; Keister, J. B. J.
Organomet. Chem. 1975, 94, C43.
(35) (a) Cotton, F. A.; Wilkinson, G. AdVanced Inorganic Chemistry, 5th
ed.; John Wiley & Sons, 1988, p 1125. (b) Evans, D. G.; Hughes, G.
R.; Mingos, D. M. P.; Bassett, J. M.; Welch, A. J. J. Chem. Soc.,
Chem. Commun. 1980, 1255. (c) Meyer, E. M.; Gambarotta, S.;
Floriani, C.; Chiesi-Villa, A.; Guastini, C. Organometallics 1989, 8,
1067. (d) Nobel, D.; van Koten, G.; Spek, A. L. Angew. Chem., Int.
Ed. Engl. 1989, 28, 209. (e) de Graaf, P. W. J.; Boersma, J.; van der
Kerk, G. J. M. J. Organomet. Chem. 1977, 127, 391. (f) Bradford, C.
W.; Nyholm, R. S.; Gainsford, G. J.; Guss, J. M.; Ireland, P. R.; Mason,
R. J. Chem. Soc., Chem. Commun. 1972, 87. (g) van Koten, G.;
Leusink, A. J.; Noltes, J. G. J. Organomet. Chem. 1974, 85, 105; 1973,
56, 379; 1974, 80, C56. (h) Schmidbaur, H.; Inoguchi, Y. Chem. Ber.
1980, 113, 1646. (i) Nesmeyanov, A. N.; Perevalova, E. G.; Granfberg,
K. I.; Lemenovskii, D. A.; Baukova, Y. V.; Afanassova, O. B. J.
Organomet. Chem. 1974, 65, 131.
(32) For leading review articles on this aspect, see: (a) Lotz, S.; van
Rooyen, P. H.; Meyer, R. AdV. Organomet. Chem. 1995, 37, 219. (b)
Holton, J.; Lappert, M.; Pearce, R.; Yarrow, P. I. W. Chem. ReV. 1983,
83, 135.
(33) (a) Pez, G. P.; Putnik, C. F.; Suib, S. L.; Stucky, G. D. J. Am. Chem.
Soc. 1979, 101, 6933. (b) Hoferkamp, L. A.; Rheinwald, G.; Stoeckli-
Evans, H.; Su¨ss-Fink, G. Organometallics 1996, 15, 704.